Abstract
Human antibody-secreting cells (ASCs) triggered by immunization are globally recognized as CD19 lo CD38 hi CD27 hi . Yet, different vaccines give rise to antibody responses of different longevity, suggesting ASC populations are heterogeneous. We define circulating-ASC heterogeneity in vaccine responses using multicolor flow cytometry, morphology, V H repertoire, and RNA transcriptome analysis. We also tested differential survival using a human cell-free system that mimics the bone marrow (BM) microniche. In peripheral blood, we identified 3 CD19 + and 2 CD19 – ASC subsets. All subsets contributed to the vaccine-specific responses and were characterized by in vivo proliferation and activation. The V H repertoire demonstrated strong oligoclonality with extensive interconnectivity among the 5 subsets and switched memory B cells. Transcriptome analysis showed separation of CD19 + and CD19 – subsets that included pathways such as cell cycle, hypoxia, TNF-α, and unfolded protein response. They also demonstrated similar long-term in vitro survival after 48 days. In summary, vaccine-induced ASCs with different surface markers (CD19 and CD138) are derived from shared proliferative precursors yet express distinctive transcriptomes. Equal survival indicates that all ASC compartments are endowed with long-lived potential. Accordingly, in vivo survival of peripheral long-lived plasma cells may be determined in part by their homing and residence in the BM microniche.
Funding Information
  • NIH/NIAID, NIH/NCATS (NIH: NIAID: R01AI121252,K23 AI67501,P01AI125180,U19AI1109962,5 P01 A1078907-04,R37AI049660,U01AI045969,Autoimmunity Center of Excellence- ARRA:AI056390-06S2,HHSN266200500030C (N01-AI50029),AI078907,AI049600,NIH/NCATS UL1 TR000454)

This publication has 61 references indexed in Scilit: